Information Library

Results for: Clinical and marketing materials - Clinical Services - Late Phase

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Quintiles Names New Global Head of Clinical & Data Operations

    Press Release — October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Population PK/PD - Modeling and Simulation Optimization Tools

    Brochure — February 11, 2011
    Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling.

  • Oversight Group Management Services - Aligned Action

    Brochure — February 2, 2011
    From data monitoring committees and endpoint adjudication to core laboratory oversight, Quintiles provides a one-stop solution for managing oversight groups.

  • The New Health Clinical Brochure

    Brochure — August 31, 2010
    Japanese version available for download.

  • Emerging Markets

    Podcast — September 29, 2009
    If you’re looking for new ways to bring development costs down, you may be considering the advantages of conducting clinical trials in emerging markets.

  • Patient Registries: A Taxonomy for the Design, Development and Implementation

    Presentation — June 25, 2009
    Recommendations from the ISPOR Patient Registry Classification, Strategy & Design Working Group, Team 2, for developing standard language for the characterization, classification, strategy, design, and execution of patient registries to generate data for outcomes research purposes.

  • Early phase strategies

    Hear from the Experts — June 15, 2009
    Web cast about Early Phase Strategies.

  • Risk Mitigation Programs

    Brochure — April 16, 2009
    Risk mitigation measures can help keep valuable drugs on the market, even when their safety profile includes adverse events that might negatively affect the benefit risk balance.

  • Risk Assessment & Strategy

    Brochure — April 16, 2009
    Quintiles benefit risk analysis can help you anticipate potential regulatory concerns and highlight the benefit side of your drug’s benefit risk profile.

Page 1 of 2 (12 results)

Subscribe to Email Based on Your Interests

Set preferences